|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2018
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/10818
Title: | Addressing access barriers to medicines in the Republic of Moldova |
Authors: | Bunazoi, Valeria |
Keywords: | medicines;access barriers;health system |
Issue Date: | 2018 |
Publisher: | MedEspera |
Citation: | BUNAZOI, Valeria. Addressing access barriers to medicines in the Republic of Moldova. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 272. |
Abstract: | Introduction. In middle-income and low-income countries, average availability of medicines is
35% in public facilities and 66% in the private sector. The prices are often unaffordable, for the
majority of population. Up to 50% of medicines are inappropriately prescribed or dispensed, and
up to 50% are used incorrectly by patients. This leads to significant wasted resources, the
potential to drive the development of drug resistance and to poor health outcomes. Many
patients, especially the poor, rely on the informal sector for their health care needs including
medicines, while respective vendors have little or no pharmacy training.
Aim of the study. Evaluation and addressing barriers of population from Republic of Moldova
to medicines trough health system perspective.
Materials and methods. Has been conducted a descriptive cross-sectional study of international
practice on strengthen policy framework on access to medicines; secondly has been initiated a
quantitative study on the population of Republic of Moldova regarding the access to medicines.
Results. According to UNDP, global access to medicines is: having drugs continuously available
and affordable at public and private health facilities or drug outlets that are within one hour's
walk of the population. Addressing access barriers to medicine has four dimensions: availability,
geographic accessibility, affordability and acceptability. Availability: medicines supply-type and
quantity and medicines demand type and quantity; affordability: prices of drug products and
services, user income and ability to pay; acceptability: characteristics of products and services,
user attitudes, expectations of products and services; accessibility: medicines supply location and
user location. Another concept assume that access is defined by rational use: rational therapeutic
choices and improved medicines’ use by consumers; affordable prices: medicines pricing
policies; sustainable financing: resource mobilization, pooling, reduction of out-of-pocket
expenditures; reliable health and supply systems: medicines procurement and supply, regulation,
human resources.
Conclusions. According with latest studies, the main health expenditure of population from
Republic of Moldova are medicines – 73,5%. In case of hospitalisation 44% of population had to
by supplementary medicines. To address barriers health system should ensure health equity,
funds, universal health coverage, health insurance, provision of essential health care services,
pay for performance, regulatory approaches, needs-based financing, integrated outreach services,
abolishment of user fees, staffed peripheral health facilities, sensitive health care delivery. |
URI: | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf http://repository.usmf.md/handle/20.500.12710/10818 |
Appears in Collections: | MedEspera 2018
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|